Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 68

Results For "LAC"

1654 News Found

Mankind Pharma tie-ups with Lepra Society to establish CDCC Centres to screen 80,000 individuals
Healthcare | February 15, 2024

Mankind Pharma tie-ups with Lepra Society to establish CDCC Centres to screen 80,000 individuals

The CDCCs are strategically positioned in regions identified as high-impact areas


Wellify adopts Unicommerce to streamline E-commerce operations
Supply Chain | February 07, 2024

Wellify adopts Unicommerce to streamline E-commerce operations

The company will be managing orders and warehouse operations for Little's, Lacto-calamine, Tri-activ, I-feel, Ourdaily, and Sloan's through the Unicommerce platform


Mandaviya inaugurates new headquarters of the National Dental Commission
News | February 06, 2024

Mandaviya inaugurates new headquarters of the National Dental Commission

Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges


DPIIT recognises 1, 17,254 startups as on Dec 2023
Startup | February 03, 2024

DPIIT recognises 1, 17,254 startups as on Dec 2023

At least one recognised startup in every State and UT; spread across over 80% of districts


Orchid Pharma's Exblifeb granted EMA approval
Drug Approval | February 01, 2024

Orchid Pharma's Exblifeb granted EMA approval

Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia


Ascletis announces dosing of the first patient in Phase III clinical trial of ASC40
Clinical Trials | January 30, 2024

Ascletis announces dosing of the first patient in Phase III clinical trial of ASC40

This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40


Merck’s Keytruda reduced the risk of death by 38% for patients with RCC
Clinical Trials | January 29, 2024

Merck’s Keytruda reduced the risk of death by 38% for patients with RCC

Keynote -564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC


Roche inaugurates new campus for Digital Centre of Excellence in Pune
News | January 26, 2024

Roche inaugurates new campus for Digital Centre of Excellence in Pune

The new campus has been designed as an employee-centred experience and ecosystem zone